Vistagen shareholders elect board, back say-on-pay and KPMG at annual meeting

Vistagen Therapeutics, Inc.

All four director nominees elected: Saxe, Cunningham, Williamson, Singh; Cunningham and Singh saw narrower support (4.66M/3.83M and 4.97M/3.53M).
Say-on-pay advisory vote approved: 6,625,045 for, 1,142,430 against, 729,413 abstentions.
KPMG LLP ratification approved as FY2027 auditor: 22,495,649 for, 680,897 against, 685,683 abstentions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.